Open Access
Antioxidants, volume 9, issue 12, pages 1240
Intravenous administration of coenzyme q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model
Obolenskaia Olga
1
,
Gorodetskaya Evgeniya
1
,
Kalenikova E I
1
,
Belousova Margarita
1
,
Gulyaev Mikhail
1
,
Makarov Valery
2
,
Pirogov Yury
3
,
Medvedev Oleg
1
2
Research and Production Association «House of Pharmacy», 188663 Saint Petersburg, Russia
|
Publication type: Journal Article
Publication date: 2020-12-07
PubMed ID:
33297323
Biochemistry
Molecular Biology
Cell Biology
Clinical Biochemistry
Physiology
Abstract
Oxidative stress plays a key role in the pathogenesis of ischemic stroke. Coenzyme Q10 has a multi-targeting effect and may protect the brain against ischemic damage. The aim of our study was to evaluate the neuroprotective potential of ubiquinol by its intravenous administration. The study was performed on rats; a stroke was modeled by occlusion of the middle cerebral artery. On days 1 and 4 after ischemia, the neurological deficit and volume of the brain lesion were determined by MRI and TTC staining. Intravenous administration of coenzyme Q10 led to a decrease in rat mortality rate, improvement in neurological status, and decrease in the brain necrosis area in acute and delayed period after cerebral ischemia. A single intravenous administration of ubiquinol led to a limitation of the size of the brain damage for at least four days after ischemia. Thus, intravenous administration of coenzyme Q10 has a persistent neuroprotective potential. This finding suggests a possible therapeutic role of ubiquinol in acute ischemic conditions.
Citations by journals
|
1
2
|
|
|
Frontiers in Neuroscience
|
Frontiers in Neuroscience
2 publications, 20%
|
|
Antioxidants
|
Antioxidants
1 publication, 10%
|
|
Pharmaceutical Chemistry Journal
|
Pharmaceutical Chemistry Journal
1 publication, 10%
|
|
Neuroscience
|
Neuroscience
1 publication, 10%
|
|
Translational Neuroscience
|
Translational Neuroscience
1 publication, 10%
|
|
Arquivos de Neuro-Psiquiatria
|
Arquivos de Neuro-Psiquiatria, 1, 10%
Arquivos de Neuro-Psiquiatria
1 publication, 10%
|
|
Frontiers in Molecular Neuroscience
|
Frontiers in Molecular Neuroscience
1 publication, 10%
|
|
Life
|
Life
1 publication, 10%
|
|
1
2
|
Citations by publishers
|
1
2
3
|
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
3 publications, 30%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 20%
|
|
Springer Nature
|
Springer Nature
1 publication, 10%
|
|
Elsevier
|
Elsevier
1 publication, 10%
|
|
Walter de Gruyter
|
Walter de Gruyter
1 publication, 10%
|
|
Associacao Arquivos de Neuro-Psiquiatria Dr. Oswaldo Lange
|
Associacao Arquivos de Neuro-Psiquiatria Dr. Oswaldo Lange, 1, 10%
Associacao Arquivos de Neuro-Psiquiatria Dr. Oswaldo Lange
1 publication, 10%
|
|
1
2
3
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2021,2022,2023,2024],"ids":[0,0,0,0],"codes":[0,0,0,0],"imageUrls":["","","",""],"datasets":[{"label":"Citations number","data":[4,2,3,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["40","20","30","10"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Frontiers in Neuroscience","Antioxidants","Pharmaceutical Chemistry Journal","Neuroscience","Translational Neuroscience","Arquivos de Neuro-Psiquiatria","Frontiers in Molecular Neuroscience","Life"],"ids":[16373,16381,1261,9057,464,14839,20786,23944],"codes":[0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/3SpVxcYL33bOvPq4sHxJLH2NeKNeDloahSUpNiO4_medium.webp","","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp"],"datasets":[{"label":"","data":[2,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[20,10,10,10,10,10,10,10],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Frontiers Media S.A.","Multidisciplinary Digital Publishing Institute (MDPI)","Springer Nature","Elsevier","Walter de Gruyter","Associacao Arquivos de Neuro-Psiquiatria Dr. Oswaldo Lange"],"ids":[208,202,8,17,4,4432],"codes":[0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/3SpVxcYL33bOvPq4sHxJLH2NeKNeDloahSUpNiO4_medium.webp",""],"datasets":[{"label":"","data":[3,2,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[30,20,10,10,10,10],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Obolenskaia O. et al. Intravenous administration of coenzyme q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model // Antioxidants. 2020. Vol. 9. No. 12. p. 1240.
GOST all authors (up to 50)
Copy
Obolenskaia O., Gorodetskaya E., Kalenikova E. I., Belousova M., Gulyaev M., Makarov V., Pirogov Y., Medvedev O. Intravenous administration of coenzyme q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model // Antioxidants. 2020. Vol. 9. No. 12. p. 1240.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/antiox9121240
UR - https://doi.org/10.3390%2Fantiox9121240
TI - Intravenous administration of coenzyme q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model
T2 - Antioxidants
AU - Obolenskaia, Olga
AU - Gorodetskaya, Evgeniya
AU - Belousova, Margarita
AU - Makarov, Valery
AU - Pirogov, Yury
AU - Medvedev, Oleg
AU - Kalenikova, E I
AU - Gulyaev, Mikhail
PY - 2020
DA - 2020/12/07 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 1240
IS - 12
VL - 9
PMID - 33297323
SN - 2076-3921
ER -
Cite this
BibTex
Copy
@article{2020_Obolenskaia,
author = {Olga Obolenskaia and Evgeniya Gorodetskaya and Margarita Belousova and Valery Makarov and Yury Pirogov and Oleg Medvedev and E I Kalenikova and Mikhail Gulyaev},
title = {Intravenous administration of coenzyme q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model},
journal = {Antioxidants},
year = {2020},
volume = {9},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {dec},
url = {https://doi.org/10.3390%2Fantiox9121240},
number = {12},
pages = {1240},
doi = {10.3390/antiox9121240}
}
Cite this
MLA
Copy
Obolenskaia, Olga, et al. “Intravenous administration of coenzyme q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model.” Antioxidants, vol. 9, no. 12, Dec. 2020, p. 1240. https://doi.org/10.3390%2Fantiox9121240.